
The 1st International Online Conference on Hematology
Part of the International Online Conference on Hematology series
28–30 October 2026



Hematology, Onco-Hematology, Leukemia, Lymphoma, Myeloma, Immunotherapy, CAR-T, Bispecific Antibodies
- Go to the Sessions
- Event Details
The IOCHE 2026 is Now OPEN for Abstract Submission and Registration!
Instructions for authors are available online.
Submit your abstracts HERE and register HERE.
IOCHE 2026 is will be FREE for participation and submission!
For any inquiries, please contact us at ioche2026@mdpi.com.
Welcome from the Chair
Welcome to this online conference, jointly organized by three MDPI hematology journals: Hemato, Hematology Reports, and Thalassemia Reports. Hematology has long been at the forefront of medical innovation, driving breakthroughs in the understanding and treatment of blood-related diseases that affect millions of people worldwide. This dynamic field covers cutting-edge research in hematopoiesis, hemostasis, transfusion medicine, and the molecular mechanisms underlying a spectrum of conditions, ranging from anemia to hematological malignancies.
This conference aims to bring together researchers and scholars to discuss a wide range of topics in hematology. We expect the conference to be a highly interactive forum, providing participants with diverse communication opportunities. It will serve as a platform to cover a broad spectrum of subjects and to publish the latest advances in the field of hematology, which have far-reaching impacts on diseases such as anemia, leukemia, and rare blood diseases. For researchers seeking rapid review and publication of their papers, these three journals are excellent choices for readers and authors due to their efficient peer review and revision processes.
Hematology Reports is the official journal of the Society of Hematologic Oncology Italy (SOHO Italy). The Spanish Society of Hematology and Hemotherapy (SEHH) and the Nuclear Medicine Discovery (Nu.Me.D.) are affiliated with Hemato. The journal Thalassemia Reports publishes recommendations and papers submitted by the Thalassemia International Federation. We look forward to early-career scholars in the society presenting their research and exchanging ideas with their esteemed colleagues.
We anticipate that attendees of this conference will share novel and inspiring ideas through short oral presentations on recent developments and discoveries, providing the wider scientific community with the latest research in the field of hematology.
Download the conference banner and share it with your colleagues!
Best wishes,
Prof. Dr. Claudio Cerchione
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola, Italy
Follow the conference organizers on Social Media:
Hematology Reports:

Hemato:


Thalassemia Reports:

Event Chairs

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola, Italy
Prof. Claudio Cerchione works in Hematology Unit of Istituto Romagnolo per lo Studio e la Cura dei Tumori “Dino Amadori” (IRST) IRCCS, where he is Head of Myeloma Clinical and Research Group in the Comprehensive Cancer Care and Research Network of Romagna and Principal Investigator of many clinical trials company sponsored and non-company sponsored. He graduated in medicine with honours from the Medical School at the University Federico II of Naples, Italy (July 2008), with a final thesis in Hematology. He started his collaboration in Hematology Department, AOU Federico II, Naples, Italy, in 2006, and there he completed with honours his Fellowship in July 2014 and his PhD program in May 2017. During his Fellowship and PhD studies, Dr. Cerchione studied in detail Hematological malignancies, and his main research topics are Multiple Myeloma and Acute Leukemias. He has spent international research experiences in Friedrich-Wilhelms Universität, Bonn, Germany, in Universitade de Coimbra, Portugal, collaborating in their clinical and research projects, and in MD Anderson Cancer Center, Houston, USA, where he has been nominated International Ambassdor of SOHO (Society of Hematologic Oncology). He is Editor or Reviewer for several highly cited international journals and member of several international societies and co-founder and President of Society of Hematologic Oncology Italy (SOHO Italy). He is author/co-author of more than one hundred papers in peer-reviewed international journals.
Session Chairs

Prof. Dr. Claudio Cerchione
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola, Italy
Prof. Claudio Cerchione works in Hematology Unit of Istituto Romagnolo per lo Studio e la Cura dei Tumori “Dino Amadori” (IRST) IRCCS, where he is Head of Myeloma Clinical and Research Group in the Comprehensive Cancer Care and Research Network of Romagna and Principal Investigator of many clinical trials company sponsored and non-company sponsored. He graduated in medicine with honours from the Medical School at the University Federico II of Naples, Italy (July 2008), with a final thesis in Hematology. He started his collaboration in Hematology Department, AOU Federico II, Naples, Italy, in 2006, and there he completed with honours his Fellowship in July 2014 and his PhD program in May 2017. During his Fellowship and PhD studies, Dr. Cerchione studied in detail Hematological malignancies, and his main research topics are Multiple Myeloma and Acute Leukemias. He has spent international research experiences in Friedrich-Wilhelms Universität, Bonn, Germany, in Universitade de Coimbra, Portugal, collaborating in their clinical and research projects, and in MD Anderson Cancer Center, Houston, USA, where he has been nominated International Ambassdor of SOHO (Society of Hematologic Oncology). He is Editor or Reviewer for several highly cited international journals and member of several international societies and co-founder and President of Society of Hematologic Oncology Italy (SOHO Italy). He is author/co-author of more than one hundred papers in peer-reviewed international journals.
Prof. Dr. Daniela Cilloni
Department of Clinical and Biological Sciences, University of Turin, Turin, Italy
-

Prof. Dr. Giuseppe Saglio
Department of Clinical and Biological Sciences, University of Turin, Turin, Italy
Giuseppe Saglio is Emeritus Professor of Haematology and Internal Medicine at the University of Turin. Professor Saglio has been coordinator of the PhD programme in Medicine and Experimental Therapy of the University of Turin and Director of the Department of Clinical and Biological Sciences of the same University. He has published more than 600 peer-reviewed articles in the fields of molecular pathogenesis of haematological diseases, molecularly targeted therapy and molecular characterization of haematological malignancies. In 2017 Prof Saglio was nominated Knight of the Italian Republic for scientific merits and for his long lasting service for the Italian University.
Registration
The registration for IOCHE 2026 will be free of charge! The registration includes attendance to all conference sessions.
If you are registering several people under the same registration, please do not use the same email address for each person, but their individual university email addresses. Thank you for your understanding.
Please note that the submission and registration are two separate parts. Only scholars who registered can receive a link to access the conference live streaming. The deadline for registration is 22 October 2026.
Instructions for Authors
IOCHE 2026 will accept abstracts only. The accepted abstracts will be available online on Sciforum.net during and after the conference.
1. Deadline for abstract submission: 29 June 2026.
2. Announcement of oral and poster abstract results: 28 July 2026. You will be notified of the acceptance of an oral/poster presentation in a separate email.
Abstract submissions should be completed online by registering with www.sciforum.net and using the "Submit Abstract" function once logged into the system. No physical template is necessary.
1. The abstract structure should include the introduction, methods, results, and conclusions sections of about 200–300 words in length.
2. All accepted abstracts will be published in the conference report of IOCHE 2026 in MDPI’s Medical Life Sciences Forum (ISSN 2673-9992) journal after quality check. If you wish to publish a research article in the journal, please refer to the “Publication Opportunities” Section.
3. All abstracts should be submitted and presented in clear, publication-ready English with accurate grammar and spelling.
4. You may submit multiple abstracts. However, only one abstract will be selected for oral presentation.
5. The abstracts submitted to this conference must be original and novel, without prior publication in any journals or it will not be accepted to this conference.
1. The submitting author must ensure that all co-authors are aware of the contents of the abstract.
2. Please select only one presenter for each submission. If you would like to change the presenter after submission, please email us accordingly.
Note: We only accept live presentations.
Poster Presentation
- Should include the title, authors, contact details and main research findings, as well as tables, figures and graphs where necessary.
- Size in pixel: 1080 width x 1536 height–portrait orientation.
- Size in cm: 38,1 width x 54,2 height–portrait orientation.
- Font size: ≥16.
- Examples of successful submissions can be viewed here at the following links: (1), (2), (3).
You can use our free template to create your poster. The poster template can be downloaded here. We will reach out to you closer to the dates of the conference with more information.
It is the authors' responsibility to identify and declare any personal circumstances or interests that may be perceived as inappropriately influencing the representation or interpretation of clinical research. If there is no conflict, please state "The authors declare no conflicts of interest." This should be conveyed in a separate "Conflicts of Interest" statement preceding the "Acknowledgments" and "References" sections at the end of the manuscript. Any financial support for the study must be fully disclosed in the "Acknowledgments" section.
MDPI, the publisher of the Sciforum.net platform, is an open access publisher. We believe authors should retain the copyright to their scholarly works. Hence, by submitting an abstract to this conference, you retain the copyright to the work, but you grant MDPI the non-exclusive right to publish this abstract online on the Sciforum.net platform. This means you can easily submit your full paper (with the abstract) to any scientific journal at a later stage and transfer the copyright to its publisher if required.
Publication Opportunities
- Publication in the Journals
Participants in this conference are cordially invited to contribute a full manuscript to the conference's Special Issue (to be announced), published jointly by Hematology Reports (ISSN 2038-8330, Impact Factor 1.2), Hemato (ISSN 2673-6357, Impact Factor 1.0) and Thalassemia Reports (ISSN 2039-4365, Impact Factor 1.2) with a 20% discount on the publication fee. Please note that if you have IOAP/association discounts, conference discounts will be combined with IOAP/association discounts. Conference discounts cannot be combined with reviewer vouchers. All submitted papers will undergo MDPI’s standard peer-review procedure. The abstracts should be cited and noted on the first page of the paper. - Proceeding Paper Publication
All accepted abstracts will be published in the conference report of IOCHE2026 in Medical Life Sciences Forum (ISSN 2673-9992); if you wish to publish an extended proceeding paper (4-8 pages), please submit it to the same journal after the conference.
Authors are asked to disclose that it is a proceeding paper of the IOCHE2026 conference paper in their cover letter. Carefully read the rules outlined in the 'Instructions for Authors' on the journal’s website and ensure that your submission adheres to these guidelines.
Proceedings submission deadline: 14 December 2026.
Manuscripts for the proceedings issue must be formatted as follows:
Title;
Full author names;
Affiliations (including full postal address) and authors' e-mail addresses;
Abstract;
Keywords;
Introduction;
Methods;
Results and Discussion;
Conclusions;
Acknowledgements;
References.
Please click HERE to submit your proceeding paper to the Medical Sciences Forum.
IOCHE2026-Proceedings-Template
Event Awards
To acknowledge the support of the conference's esteemed authors and recognize their outstanding scientific accomplishments, we are pleased to launch the Best Oral Presentation Award and Best Poster Award.
The Awards
Number of Awards Available: 6
The Best Oral Presentation Award is given to the paper judged to make the most significant oral contribution to the conference.
The Best Poster Award is given to the submission judged to make the most significant and interesting poster for the conference.
There will be six winners selected for these awards. The winner will receive a certificate and 200 CHF each.
Sponsors and Partners
For information regarding sponsorship and exhibition opportunities, please click here.
Organizers
Media Partners
Conference Secretariat
Ms. Ioana Vintila
Ms. Winnie Wu
Ms. Maisie Ma
Ms. Christy Cui
Email: ioche2026@mdpi.com
For inquiries regarding submissions and sponsorship opportunities, please feel free to contact us.